Pharmacology, School of Nursing, Kanazawa Medical University, Ishikawa, Japan.
Biol Pharm Bull. 2011;34(8):1307-13. doi: 10.1248/bpb.34.1307.
The regulatory role of plasma nitrosothiols (R-SNOs) under steady-state conditions and their possible contribution to pharmacological vasodilation were systematically examined in anesthetized rabbits. Nitrosocystein (Cys-NO), S-nitrosoglutathione (G-SNO), and S-nitrosoalbumin (Alb-SNO) were determined by HPLC-Saville's method with respective sensitivities of 1, 1, and 5 nM. These R-SNOs were not detected under steady-state conditions even in the presence of N-ethylmaleimide, a thiol protective agent used to prevent transnitrosation of R-SNOs. Development of plasma Alb-SNO below 300 nM was observed after intravenous injection (i.v.) of nitric oxide (NO) solution (0.1 to 3 ml/g), NOC7 (an NO releasing agent, above 1 µg/kg), and a low dose of Alb-SNO (10 nmol/kg). However, blood pressure was not significantly reduced by NO solution or Alb-SNO. Intravenous injection of a high dose of Alb-SNO (300 nmol/kg) significantly reduced blood pressure with the appearance not only Alb-SNO in micromolar level in plasma, but also G-SNO in lesser degree. Conversely, the hypotensive effect of Cys-NO (300 nmol/kg, i.v.) and G-SNO (300 nmol/kg, i.v.) accompanied development of Alb-SNO (micromolar level), but not Cys-NO or G-SNO in plasma. R-SNOs were not found in plasma during profound hypotension induced by acetylcholine (10 and 30 µg/kg/min, continuous i.v.), glyceryl trinitrate (100 µg/kg, i.v.), sodium nitroprusside (100 µg/kg, i.v.), and isosorbide dinitrate (300 µg/kg, i.v.). These results indicate that R-SNOs do not play an important role under unstimulated condition. In addition, plasma R-SNOs may not be involved in pharmacological vasodilation where contributions of NO or R-SNOs are suggested.
在麻醉兔中,系统研究了在稳态条件下血浆硝硫醇(R-SNOs)的调节作用及其对药理学血管舒张的可能贡献。采用 HPLC-Saville 法测定硝半胱氨酸(Cys-NO)、S-亚硝基谷胱甘肽(G-SNO)和 S-亚硝基白蛋白(Alb-SNO),其灵敏度分别为 1、1 和 5 nM。即使在使用硫醇保护剂 N-乙基马来酰亚胺以防止 R-SNOs 的反硝酰化的情况下,在稳态条件下也未检测到这些 R-SNOs。静脉注射一氧化氮(NO)溶液(0.1 至 3 ml/g)、NOC7(一种 NO 释放剂,超过 1 µg/kg)和低剂量 Alb-SNO(10 nmol/kg)后,观察到血浆 Alb-SNO 降低至 300 nM 以下。然而,NO 溶液或 Alb-SNO 并未显著降低血压。静脉注射高剂量 Alb-SNO(300 nmol/kg)显著降低血压,不仅使 Alb-SNO 出现在血浆中亚微米水平,而且使 G-SNO 程度较低。相反,Cys-NO(300 nmol/kg,静脉注射)和 G-SNO(300 nmol/kg,静脉注射)的降压作用伴随着 Alb-SNO(亚微米水平)的发展,但血浆中没有 Cys-NO 或 G-SNO。在乙酰胆碱(10 和 30 µg/kg/min,连续静脉注射)、甘油三硝酸酯(100 µg/kg,静脉注射)、硝普钠(100 µg/kg,静脉注射)和异山梨醇二硝酸酯(300 µg/kg,静脉注射)引起的严重低血压期间,未在血浆中发现 R-SNOs。这些结果表明,在未受刺激的情况下,R-SNOs 不起重要作用。此外,在药理学血管舒张中,可能不涉及血浆 R-SNOs,其中建议了 NO 或 R-SNOs 的贡献。